(Q38108676)

29 August 2017

title

The mTOR signaling pathway in pediatric neuroblastoma (English)

1 reference

29 August 2017

Hong Mei

1

1 reference

29 August 2017

Ye Wang

series ordinal

2

1 reference

29 August 2017

Zhenyu Lin

series ordinal

3

1 reference

29 August 2017

Qiangsong Tong

series ordinal

4

1 reference

29 August 2017

publication date

22 May 2013

1 reference

Pediatric Hematology and Oncology

29 August 2017

published in

1 reference

29 August 2017

volume

30

1 reference

29 August 2017

issue

7

1 reference

29 August 2017

page(s)

605-615

1 reference

Neuroblastoma: biological insights into a clinical enigma

29 August 2017

cites work

1 reference

https://api.crossref.org/works/10.3109%2F08880018.2013.798058

Children's Oncology Group's 2013 blueprint for research: neuroblastoma

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F08880018.2013.798058

Neuroblastoma: biology, prognosis, and treatment

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F08880018.2013.798058

mTOR signaling in growth control and disease

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F08880018.2013.798058

Novel approaches for molecular targeted therapy of breast cancer: interfering with PI3K/AKT/mTOR signaling

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F08880018.2013.798058

Pivotal role of mTOR signaling in hepatocellular carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F08880018.2013.798058

Regulation and importance of the PI3K/Akt/mTOR signaling pathway in hematologic malignancies

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F08880018.2013.798058

Dominant missense mutations in a novel yeast protein related to mammalian phosphatidylinositol 3-kinase and VPS34 abrogate rapamycin cytotoxicity

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F08880018.2013.798058

Target of rapamycin in yeast, TOR2, is an essential phosphatidylinositol kinase homolog required for G1 progression

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F08880018.2013.798058

Signaling by target of rapamycin proteins in cell growth control

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F08880018.2013.798058

An evolving role for DEPTOR in tumor development and progression

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F08880018.2013.798058

Tti1 and Tel2 are critical factors in mammalian target of rapamycin complex assembly

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F08880018.2013.798058

Raptor, a binding partner of target of rapamycin

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F08880018.2013.798058

Proline-rich Akt substrate of 40kDa (PRAS40): a novel downstream target of PI3k/Akt signaling pathway.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F08880018.2013.798058

Identification of Protor as a novel Rictor-binding component of mTOR complex-2

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F08880018.2013.798058

Protor-1 is required for efficient mTORC2-mediated activation of SGK1 in the kidney

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F08880018.2013.798058

mSin1 is necessary for Akt/PKB phosphorylation, and its isoforms define three distinct mTORC2s

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F08880018.2013.798058

Effects of small molecule inhibitors of PI3K/Akt/mTOR signaling on neuroblastoma growth in vitro and in vivo

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F08880018.2013.798058

Oncogenic PI3K and its role in cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F08880018.2013.798058

Status of PI3K inhibition and biomarker development in cancer therapeutics

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F08880018.2013.798058

Regulation of phosphoinositide 3-kinase expression in health and disease

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F08880018.2013.798058

PI3K/Akt and apoptosis: size matters

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F08880018.2013.798058

Protein kinase B (c-Akt) in phosphatidylinositol-3-OH kinase signal transduction

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F08880018.2013.798058

Targeting the phosphoinositide 3-kinase isoform p110delta impairs growth and survival in neuroblastoma cells.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F08880018.2013.798058

PRAS40 is an insulin-regulated inhibitor of the mTORC1 protein kinase

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F08880018.2013.798058

PRAS40 and PRR5-like protein are new mTOR interactors that regulate apoptosis.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F08880018.2013.798058

Phosphorylation and regulation of Akt/PKB by the rictor-mTOR complex

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F08880018.2013.798058

Activation of Akt predicts poor outcome in neuroblastoma

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F08880018.2013.798058

AMP-activated protein kinase: new regulation, new roles?

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F08880018.2013.798058

Calmodulin-dependent protein kinase kinase-beta is an alternative upstream kinase for AMP-activated protein kinase

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F08880018.2013.798058

The Ca2+/calmodulin-dependent protein kinase kinases are AMP-activated protein kinase kinases

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F08880018.2013.798058

The tumor suppressor LKB1 kinase directly activates AMP-activated kinase and regulates apoptosis in response to energy stress

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F08880018.2013.798058

TSC2 mediates cellular energy response to control cell growth and survival

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F08880018.2013.798058

Autophagy-dependent and -independent involvement of AMP-activated protein kinase in 6-hydroxydopamine toxicity to SH-SY5Y neuroblastoma cells.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F08880018.2013.798058

AMP-activated protein kinase promotes human prostate cancer cell growth and survival

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F08880018.2013.798058

Down-regulation of AMP-activated protein kinase sensitizes DU145 carcinoma to Fas-induced apoptosis via c-FLIP degradation

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F08880018.2013.798058

The regulation and function of mammalian AMPK-related kinases.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F08880018.2013.798058

LKB1 is a master kinase that activates 13 kinases of the AMPK subfamily, including MARK/PAR-1

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F08880018.2013.798058

A serine/threonine kinase gene defective in Peutz-Jeghers syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F08880018.2013.798058

LKB1/AMPK/mTOR signaling pathway in hematological malignancies: from metabolism to cancer cell biology.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F08880018.2013.798058

Arsenic inhibits neurite outgrowth by inhibiting the LKB1-AMPK signaling pathway

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F08880018.2013.798058

Nuclear localization and regulation of erk- and rsk-encoded protein kinases

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F08880018.2013.798058

Mitogen-activated protein kinase pathways

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F08880018.2013.798058

The MAPK signalling pathways and colorectal cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F08880018.2013.798058

Mammalian MAP kinase signalling cascades

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F08880018.2013.798058

Targeting the Raf-MEK-ERK mitogen-activated protein kinase cascade for the treatment of cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F08880018.2013.798058

High nuclear expression of phosphorylated extracellular signal-regulated kinase in tumor cells in colorectal glands is associated with poor outcome in colorectal cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F08880018.2013.798058

Down-regulation of growth factor-stimulated MAP kinase signaling in cytotoxic drug-resistant human neuroblastoma cells

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F08880018.2013.798058

Identification of the tuberous sclerosis gene TSC1 on chromosome 9q34

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F08880018.2013.798058

Tuberous sclerosis: a GAP at the crossroads of multiple signaling pathways

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F08880018.2013.798058

Rheb GTPase is a direct target of TSC2 GAP activity and regulates mTOR signaling

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F08880018.2013.798058

Tuberin and hamartin are aberrantly expressed and linked to clinical outcome in human breast cancer: the role of promoter methylation of TSC genes

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F08880018.2013.798058

Tuberous sclerosis complex (TSC) gene involvement in sporadic tumours

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F08880018.2013.798058

The farnesyl transferase inhibitor (FTI) SCH66336 (lonafarnib) inhibits Rheb farnesylation and mTOR signaling. Role in FTI enhancement of taxane and tamoxifen anti-tumor activity

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F08880018.2013.798058

A novel approach for expression cloning of small GTPases: identification, tissue distribution and chromosome mapping of the human homolog of rheb

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F08880018.2013.798058

Tenets of PTEN tumor suppression

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F08880018.2013.798058

PI3K signaling in glioma--animal models and therapeutic challenges

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F08880018.2013.798058

Analysis of PTEN/MMAC1 alteration in neuroblastoma.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F08880018.2013.798058

Homozygous deletion and expression of PTEN and DMBT1 in human primary neuroblastoma and cell lines

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F08880018.2013.798058

FOXO3a is a major target of inactivation by PI3K/AKT signaling in aggressive neuroblastoma

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F08880018.2013.798058

NF1 is a tumor suppressor in neuroblastoma that determines retinoic acid response and disease outcome

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F08880018.2013.798058

Current development of mTOR inhibitors as anticancer agents

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F08880018.2013.798058

Targeting tumorigenesis: development and use of mTOR inhibitors in cancer therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F08880018.2013.798058

Rapamycin increases neuroblastoma xenograft and host stromal derived osteoprotegerin inhibiting osteolytic bone disease in a bone metastasis model

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F08880018.2013.798058

Combination of an allosteric Akt Inhibitor MK-2206 with etoposide or rapamycin enhances the antitumor growth effect in neuroblastoma.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F08880018.2013.798058

Inhibitors of mammalian target of rapamycin downregulate MYCN protein expression and inhibit neuroblastoma growth in vitro and in vivo

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F08880018.2013.798058

Phase I study of temsirolimus in pediatric patients with recurrent/refractory solid tumors

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F08880018.2013.798058

Activation of the phosphatidylinositol 3'-kinase/AKT pathway in neuroblastoma and its regulation by thioredoxin 1.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F08880018.2013.798058

Targeting aberrant PI3K/Akt activation by PI103 restores sensitivity to TRAIL-induced apoptosis in neuroblastoma.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F08880018.2013.798058

Inhibition of phosphatidylinositol 3-kinase destabilizes Mycn protein and blocks malignant progression in neuroblastoma.

21 January 2018

1 reference

https://api.crossref.org/works/10.3109%2F08880018.2013.798058

10.3109/08880018.2013.798058

21 January 2018

Identifiers

DOI

1 reference

29 August 2017

1 reference